New cancer clinical trial: A Study to Reveal the Patient Characteristics and Treatment Patterns of Stage III Non-small-cell Lung Cancer Patients

Published on: October 31, 2018 at 12:00PM
Condition:   Non-small-cell Lung Cancer (NSCLC)
Intervention:  
Sponsor:   AstraZeneca
Not yet recruiting
https://ift.tt/2Rs0I8l